Targeting the metabolism of glycosphingolipids as a novel therapeutic strategy for MND (Cure for MND grant administered by the Florey Institute of Neuroscience and Mental Health) (2017–2021)
Grant type:
The Florey Institute of Neuroscience and Mental Health